Improved performance of SPECT-CT In-111 capromab pendetide by correlation with diffusion-weighted magnetic resonance imaging for identifying metastatic pelvic lymphadenopathy in prostate cancer.

Improved performance of SPECT-CT In-111 capromab pendetide by correlation with diffusion-weighted magnetic resonance imaging for identifying metastatic pelvic lymphadenopathy in prostate cancer. World J Urol. 2013 Dec; 31(6):1327-32.

View in: PubMed

subject areas

Aged
Antibodies, Monoclonal
Diffusion Magnetic Resonance Imaging
Humans
Indium Radioisotopes
Lymph Nodes
Lymphatic Metastasis
Male
Middle Aged
Pelvic Neoplasms
Prospective Studies
Prostate
Prostatic Neoplasms
Retrospective Studies
Sensitivity and Specificity
Tomography, Emission-Computed, Single-Photon
Tomography, X-Ray Computed

authors with profiles

William J. Rieter
Andrew D Hardie
Thomas E. Keane
Leonie L Gordon